Return On Assets in % of Chemomab Therapeutics Ltd. from Q3 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Return On Assets history and change rate from Q3 2020 to Q2 2023.
  • Chemomab Therapeutics Ltd. Return On Assets for the quarter ending 30 Jun 2023 was -84.2 %, a 172% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Return On Assets for 2022 was -52.5 %, a 176% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Return On Assets for 2021 was -19 %, a 63.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Chemomab Therapeutics Ltd. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -84.2 -53.2 -172% 01 Apr 2023 30 Jun 2023
Q1 2023 -67.8 -43.7 -181% 01 Jan 2023 31 Mar 2023
Q4 2022 -52.5 -33.5 -176% 01 Oct 2022 31 Dec 2022
Q3 2022 -42.1 -24.3 -136% 01 Jul 2022 30 Sep 2022
Q2 2022 -31 -10.7 -52.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -24.1 +2.28 +8.64% 01 Jan 2022 31 Mar 2022
Q4 2021 -19 +33.5 +63.7% 01 Oct 2021 31 Dec 2021
Q3 2021 -17.8 +55.1 +75.5% 01 Jul 2021 30 Sep 2021
Q2 2021 -20.3 01 Apr 2021 30 Jun 2021
Q1 2021 -26.4 01 Jan 2021 31 Mar 2021
Q4 2020 -52.5 01 Oct 2020 31 Dec 2020
Q3 2020 -73 01 Jul 2020 30 Sep 2020

Chemomab Therapeutics Ltd. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 -52.5 -33.5 -176% 01 Jan 2022 31 Dec 2022
2021 -19 +33.5 +63.7% 01 Jan 2021 31 Dec 2021
2020 -52.5 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.